Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Protagonist Therapeutics Has Randomized 241 Patients In Phase 3 VERIFY Trial Of Rusfertide In Polycythemia Vera, Expects To Meet 250 Enrollment Target By End Of March, Topline Data Is Expected in Q1 2025

Author: Benzinga Newsdesk | March 26, 2024 07:17am

Posted In: PTGX